DNUT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Krispy Kreme Inc (DNUT) does not present a strong buy opportunity for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock's technical indicators, options data, and financial performance do not suggest a compelling entry point at this time. While there are positive catalysts in promotional strategies and hedge fund interest, the overall financial health and lack of strong upward momentum make it prudent to hold off on buying.
The MACD histogram is slightly positive at 0.0073, indicating weak bullish momentum, but it is contracting. RSI is neutral at 35.219, showing no clear overbought or oversold condition. Moving averages are converging, suggesting indecision in price direction. The stock is near its support level (S1: 3.224), but there is no strong technical indication of a rebound.
Krispy Kreme's recent promotional strategies, including the St. Patrick's Day doughnut collection and discounted pricing, have positively impacted brand visibility and customer engagement. Hedge fund buying activity has increased significantly by 115.53% over the last quarter, indicating institutional interest.
The company's financial performance in Q4 2025 shows declining revenue (-5.31% YoY) and gross margin (-8.05% YoY), which raises concerns about profitability and operational efficiency. Analyst ratings remain mixed, with no significant upgrades to 'Buy' and modest price target increases.
In Q4 2025, Krispy Kreme's revenue dropped by 5.31% YoY to $382.56M. However, net income improved by 23.78% YoY to -$27.78M, and EPS increased by 23.08% YoY to -$0.16. Despite these improvements, the company remains unprofitable, and gross margin declined to 16.23%, reflecting operational challenges.
Analyst ratings are mixed. Evercore ISI and Citi raised their price targets slightly to $4.50 and $4, respectively, but maintain neutral ratings. BofA lowered its price target to $5 while maintaining a Buy rating. Morgan Stanley raised its target to $3 but keeps an Underweight rating. Overall, analysts do not show strong conviction in the stock's upside potential.
